CellSource Co., Ltd.

Tokyo Stock Exchange 4880.T

CellSource Co., Ltd. Return on Assets (ROA) for the year ending October 31, 2024: 3.36%

CellSource Co., Ltd. Return on Assets (ROA) is 3.36% for the year ending October 31, 2024, a -74.94% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

CellSource Co., Ltd. Return on Assets (ROA) for the year ending October 31, 2023 was 13.42%, a -39.36% change year over year.
CellSource Co., Ltd. Return on Assets (ROA) for the year ending October 31, 2022 was 22.13%, a 14.32% change year over year.
CellSource Co., Ltd. Return on Assets (ROA) for the year ending October 31, 2021 was 19.36%, a 66.11% change year over year.
CellSource Co., Ltd. Return on Assets (ROA) for the year ending October 31, 2020 was 11.65%, a 7.55% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Tokyo Stock Exchange: 4880.T

CellSource Co., Ltd.

CEO	Mr. Takashi Sawada
IPO Date	Oct. 29, 2019
Location	Japan
Headquarters	Shibuya Mitake Building
Employees	151
Sector	Healthcare
Industries Biotechnology Composite Materials Consumer Packaged Goods Cosmetics Eyewear Personal Care Pharmaceuticals Plastics

Description

CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years